Medicis Pharmaceutical Aktie
WKN: 881835 / ISIN: US5846903095
08.10.2025 13:48:34
|
Marex Group Preliminary Q3 Results Climb
(RTTNews) - Marex Group PLC (MRX), a financial services provider, on Wednesday reported a rise in preliminary earnings and revenue for the third quarter.
For the three-month period to September 30, the company expects a net income of $70 million to $73 million, or $0.88 per share to $0.93 per share.
For the third quarter of 2024, the company had recorded a net profit of $58 million, or $0.73 per share.
Excluding items, income is anticipated to be $69 million to $73 million, or $0.92 to $0.97 per share.
For the third quarter of 2024, the Group had posted an adjusted profit of $58 million, or $0.76 per share.
Marex Group projects revenue of $475 million to $485 million, up from last year's $391 million.
On average, analysts polled forecast the company to earn $0.91 per share on revenue of $475.36 million for the quarter. Analysts' estimates typically exclude special items.
MRX was up by 2.34% at $28.90 in the pre-market trade on the Nasdaq.

Wenn Sie mehr über das Thema Aktien erfahren wollen, finden Sie in unserem Ratgeber viele interessante Artikel dazu!
Jetzt informieren!
Nachrichten zu Medicis Pharmaceutical Corp.mehr Nachrichten
Keine Nachrichten verfügbar. |